UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder

BMC psychiatry, 2024-04, Vol.24 (1), p.244-244, Article 244

2024

Volltextzugriff (PDF)

Treating Tobacco Use Disorder in Pregnant Women in Medication-Assisted Treatment for an Opioid Use Disorder: A Systematic Review

Journal of substance abuse treatment, 2015-05, Vol.52, p.40-47

2015

Volltextzugriff (PDF)

Antagonist Treatment for Opioid Use Disorder

The American journal of medicine, 2017-03, Vol.130 (3), p.e117-e117

2017

Volltextzugriff (PDF)

Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism

Addiction (Abingdon, England), 2020-02, Vol.115 (2), p.239-246

2020

Volltextzugriff (PDF)

Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials

Drug and alcohol dependence, 2022-04, Vol.233, p.109343-109343, Article 109343

2022

Volltextzugriff (PDF)

Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial

Addictive behaviors, 2020-12, Vol.111, p.106538-106538, Article 106538

2020

Volltextzugriff (PDF)

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial

Drug and alcohol dependence, 2018-06, Vol.187, p.171-178

2018

Volltextzugriff (PDF)

Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting

The American journal on addictions, 2022-03, Vol.31 (2), p.142-147

2022

Volltextzugriff (PDF)

Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018

Drug safety, 2021-03, Vol.44 (3), p.351-359

2021

Volltextzugriff (PDF)

Patterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone

The American journal of drug and alcohol abuse, 2021-11, Vol.47 (6), p.753-759

2021

Volltextzugriff (PDF)

Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism

Addiction (Abingdon, England), 2020-11, Vol.115 (11), p.2188-2190

2020

Volltextzugriff (PDF)

Opioid Prescription Dispensing Patterns in Patients with Bipolar Disorder: Real-World Evidence from the IBM Market Scan Research Databases

CNS spectrums, 2022-04, Vol.27 (2), p.232-233

2022

Volltextzugriff (PDF)

Extended‐release naltrexone (XR‐NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry

Addiction (Abingdon, England), 2018-08, Vol.113 (8), p.1477-1487

2018

Volltextzugriff (PDF)

Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended‐Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens

The American journal on addictions, 2020-07, Vol.29 (4), p.313-322

2020

Volltextzugriff (PDF)

An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder

Alcohol (Fayetteville, N.Y.), 2016-06, Vol.53, p.45-50

2016

Volltextzugriff (PDF)

Psychoeducational Strategies During Outpatient Transition to Extended-Release Naltrexone for Patients With Opioid Use Disorder

Journal of the American Psychiatric Nurses Association, 2019-07, Vol.25 (4), p.272-279

2019

Volltextzugriff (PDF)

Opiate Dependence in Schizophrenia: Case Presentation and Literature Review

Journal of dual diagnosis, 2014-01, Vol.10 (1), p.52-57

2014

Volltextzugriff (PDF)

Sleep in Schizophrenia and Substance Use Disorders: A Review of the Literature

Journal of dual diagnosis, 2013-08, Vol.9 (3), p.228-238

2013

Volltextzugriff (PDF)

Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders

Current addiction reports, 2014-12, Vol.1 (4), p.251-260

2014

Volltextzugriff (PDF)

A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report

Journal of dual diagnosis, 2015-01, Vol.11 (3-4), p.248-257

2015

Volltextzugriff (PDF)

Dextromethorphan Abuse and Dependence in Adolescents

Journal of dual diagnosis, 2010-12, Vol.6 (3-4), p.266-278

2010

Volltextzugriff (PDF)

Reply to Kunoe (2020) and Ghosh and Singh (2020) regarding: Nunes et al., Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction. 2020 Feb;115(2):239-246

Addiction (Abingdon, England), 2020-07, Vol.115 (11), p.2188-2190

2020

Volltextzugriff (PDF)

Surgisis Mesh Repair of a Postsacrectomy Perineal Hernia Along with Posterior Proctosigmoidectomy for Concomitant Stricture

The American surgeon, 2007-11, Vol.73 (11), p.1129-1132

2007

Volltextzugriff (PDF)

Somnotate: A probabilistic sleep stage classifier for studying vigilance state transitions

PLoS computational biology, 2024-01, Vol.20 (1), p.e1011793-e1011793

2024

Volltextzugriff (PDF)

Intracellular chloride regulation mediates local sleep pressure in the cortex

Nature neuroscience, 2023-01, Vol.26 (1), p.64-78

2023

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(22)
Substance Abuse
(16)
Psychiatry
(14)
Opioid-Related Disorders - Drug Therapy
(10)
Female
(8)
Social Sciences
(8)
Adult
(7)
Drug Abuse
(7)
Male
(7)
Naltrexone
(7)
Narcotics
(7)
Psychology
(7)
Psychology, Clinical
(7)
Naltrexone - Therapeutic Use
(6)
Narcotic Antagonists - Therapeutic Use
(6)
Opioids
(6)
Patients
(6)
Substance Abuse Treatment
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder

Treating Tobacco Use Disorder in Pregnant Women in Medication-Assisted Treatment for an Opioid Use Disorder: A Systematic Review

Antagonist Treatment for Opioid Use Disorder

Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism

Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials

Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial

Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting

Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018

Patterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone

Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended‐release naltrexone in a controlled trial: implications for mechanism

Opioid Prescription Dispensing Patterns in Patients with Bipolar Disorder: Real-World Evidence from the IBM Market Scan Research Databases

Extended‐release naltrexone (XR‐NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry

Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended‐Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens

An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder

Psychoeducational Strategies During Outpatient Transition to Extended-Release Naltrexone for Patients With Opioid Use Disorder

Opiate Dependence in Schizophrenia: Case Presentation and Literature Review

Sleep in Schizophrenia and Substance Use Disorders: A Review of the Literature

Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders

A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report

Dextromethorphan Abuse and Dependence in Adolescents

Reply to Kunoe (2020) and Ghosh and Singh (2020) regarding: Nunes et al., Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction. 2020 Feb;115(2):239-246

Surgisis Mesh Repair of a Postsacrectomy Perineal Hernia Along with Posterior Proctosigmoidectomy for Concomitant Stricture

Somnotate: A probabilistic sleep stage classifier for studying vigilance state transitions

Intracellular chloride regulation mediates local sleep pressure in the cortex

Suchergebnisse filtern